Abstract
Leflunomide has several properties that make it an excellent candidate for use in transplantation, but concerns about the prolonged half-life and potential for hepatotoxicity temper the enthusiasm. As it will likely be several years before similar, shorter acting agents are available, continued study is warranted to discern the appropriate use in human transplantation of this currently available agent.
Original language | English (US) |
---|---|
Pages (from-to) | 317-322 |
Number of pages | 6 |
Journal | Current opinion in organ transplantation |
Volume | 8 |
Issue number | 4 |
DOIs | |
State | Published - Jan 1 2003 |
Externally published | Yes |
Keywords
- Dosing
- Kinetics
- Leflunomide
- Malononitrilamide
- Transplantation
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation